PATENT CLAIM ANALYSIS

Application Number: 16124578
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-04
Patent Classification: ["514", "234200"]

Abstract:
The present invention provides methods for treating a cancer in a subject and for inhibiting tumor growth, metastasis or a dihydrorotate oxygenase enzyme activity of a tumor or cancer cell. At least one trisubstituted benzotriazole derivative with the formula (I) is administered to the subject or is contacted with the cancer cell. Compounds of formula (I) have substituents R 1 , R 2  and R 3  which have the meanings given in the specification, and pharmaceutically acceptable salts thereof.

Claim (Index 28):
The method according to  claim 18 , wherein the compound is or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 97.0
- Lexical Diversity: 1.57143
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15494820', '15718961', '14784708', '15737351', '13262640']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7583950919795401
- 35 USC 102 Novelty (BERT): 0.5270370379092562
- Combined Prediction Score: 0.7352592865725117
- Mean Citation Score: 294.006844
- Max Citation Score: 328.6353
- Similarity Product: 278.6494899502158

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test